Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Advocacy (policy advocacy, lobbying)
Across all conditions/Other (1)
Pharmaceutical Company (9)
Health Technology Assessment (HTA) bodies
Transparency in communication and documentation
Clinical study phase II